A team of German researchers identified the four-microRNA signature and said it might inform treatment decisions.
In an analysis of glioblastoma, the researchers identified changes in protein signaling linked to resistance as early as several days after treatment.
ISB President and Co-founder Lee Hood will join Providence as senior VP and chief science officer as the partners join forces on research.
Two Boston-based researchers shared methods for detecting circulating nucleic acid biomarkers for potential use in cancer diagnosis and monitoring.
In Phase II testing, the company has shown that an epigenetic biomarker associated with the drug's target can predict patients' responses to treatment.
The method, developed by scientists at Uppsala University in Sweden, uses antibody-based proximity assays alongside off-the-shelf gene expression assays.
Through comprehensive genomic profiling, researchers identified molecular events that cause lower grade gliomas to progress to more deadly forms of brain cancer.
In PLOS this week: genetic diversity of Theileria annulata parasite, gene expression patterns in glioblastoma, and more.
An Institute of Cancer Research-led team conducted a meta-analysis that uncovered five new variants linked to glioma development, including one that greatly increases risk of glioblastoma.
The unique stem cells may be the key to understanding how the primate brain grew and expanded during evolution.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.